Trimel Biopharma SRL
Records under this name other than patents Trimel Biopharma SRL holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Trimel Biopharma SRL
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,661,425 | Inhaler Formerly held Term ended Term ended Jun 16, 2026 · High confidence | Term ended | Term ended Jun 16, 2026 | High confidence |
| US 9,757,388 | Intranasal Methods of Treating Women for Anorgasmia with 0.6% and 0.72% Testosterone Gels Formerly held Lapsed on the fee record Ended Sep 12, 2025 · High confidence | Lapsed on the fee record | Ended Sep 12, 2025 | High confidence |
| US 6,648,848 | Inhaler for powdered medicaments Formerly held Term ended Term ended Jan 12, 2020 · USPTO record | Term ended | Term ended Jan 12, 2020 | USPTO record |
| US 6,811,543 | Method for Introducing a Powdered Substance into a Nostril Formerly held Term ended Term ended Sep 17, 2018 · Medium confidence | Term ended | Term ended Sep 17, 2018 | Medium confidence |
| US 5,797,392 | Inhaler Formerly held Term ended Term ended no later than Aug 25, 2018 · Low confidence | Term ended | Term ended no later than Aug 25, 2018 | Low confidence |